A meta-analysis of subcutaneous immunoglobulin safety and efficacy for maintenance therapy in CIDP скачать в хорошем качестве

A meta-analysis of subcutaneous immunoglobulin safety and efficacy for maintenance therapy in CIDP

Muhammad Yousaf, MD, Virginia Tech Carilion School of Medicine, Roanoke, VA, discusses a meta-analysis investigating the safety and efficacy of subcutaneous immunoglobulin (SCIg) as maintenance therapy in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). The findings reveal a significant decrease in relapse rate and improvement in disability scores with SCIg compared with placebo. Dr Yousaf highlights the need for further trials to confirm the safety and efficacy of SCIg. This interview took place at the 77th American Academy of Neurology (AAN) Annual Meeting in San Diego, CA. These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.